On the morning of October 12, the Guangdong Provincial Drug Administration issued a document entitled "List of Pilot Approved Products for the Medical Device Registrant System in Guangdong Province (as of 2021-10-8)."
Documents show that Huawei wrist single-conductive electrocardiogram collector belongs to the second category of medical equipment, registration number "Guangdong Armory Note 20202071705", the trustee is Gore Co., Ltd., Weifang Jing gaoke Electronic Technology Co., Ltd., the approval date is September 10, 2021, valid until October 22, 2025.
AI Financial News learned that in May 2021, He Gang, president of Huawei's consumer business mobile phone product line, revealed that Huawei's first blood pressure-measuring smartwatch has passed the medical device registration test and is expected to be available in the second half of the year.
In addition, as early as August 23, the Guangdong Provincial Drug Administration issued the "Guangdong Province, the second category of medical device priority approval application approval results (Issue 49)" shows that Huawei has three medical devices into the priority approval process, namely, wrist electrocardiogram (MLY-B10, MLY-B11), electrocardiogram analysis system (ECG-1), heart rate disorder analysis system (PPG-1).
Huawei Terminal Co., Ltd. and Huawei Technologies Co., Ltd. have now disclosed a number of medical-related patents, such as the 2016 application for "a heart rate detection method and device" "heart rate detection method and system", while Huawei can reduce the design and manufacture of electrocardiogram detection device "an electrocardiogram detection device" patent, can improve the accuracy of electrocardiogram "electrocardiogram device, circuit and method" patent. At present, Huawei Technologies Co., Ltd. has more than 100 trademark registration applications classified as "medical devices" internationally, and 44 have completed registration.